Skip to main content
Top
Published in: International Urology and Nephrology 1/2014

01-09-2014 | Urology - Original Paper

Defining and advancing education and conservative therapies of underactive bladder

Authors: Tomas L. Griebling, Catherine E. DuBeau, George Kuchel, Mary H. Wilde, Michelle Lajiness, Hikaru Tomoe, Ananias Diokno, Andrew Vereecke, Michael B. Chancellor

Published in: International Urology and Nephrology | Special Issue 1/2014

Login to get access

Abstract

In contrast to other forms of voiding dysfunction, underactive bladder (UAB) has traditionally received little research or educational attention. This is changing as our understanding of the underlying mechanisms of detrusor dysfunction and other forms of underactive bladder improves. In addition, the impact of UAB on patient symptoms, general and health-related quality of life, and caregiver burden are becoming more recognized. However, there remains a paucity of data on the subject, and an extensive need for additional research and education on the topic. This paper explores the current state of knowledge about UAB with an emphasis on education regarding the condition and conservative methods of assessment and treatment. Recommendations for future work in this area are considered.
Literature
1.
go back to reference Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-committee of the International Continence S (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178 Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-committee of the International Continence S (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178
2.
go back to reference Resnick NMEA, Yalla SV (1995) Age and the lower urinary tract: what is normal? Neurourol Urodyn 14:577–579 Resnick NMEA, Yalla SV (1995) Age and the lower urinary tract: what is normal? Neurourol Urodyn 14:577–579
5.
go back to reference Nuotio M, Tammela TL, Luukkaala T, Jylha M (2003) Predictors of institutionalization in an older population during a 13-year period: the effect of urge incontinence. J Gerontol A Biol Sci Med Sci 58(8):756–762PubMedCrossRef Nuotio M, Tammela TL, Luukkaala T, Jylha M (2003) Predictors of institutionalization in an older population during a 13-year period: the effect of urge incontinence. J Gerontol A Biol Sci Med Sci 58(8):756–762PubMedCrossRef
7.
go back to reference Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, Oh JJ, Lee SC, Jeong CW, Yoon CY, Hong SK, Byun SS, Lee SE (2012) Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol 53(5):342–348. doi:10.4111/kju.2012.53.5.342 PubMedCrossRefPubMedCentral Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, Oh JJ, Lee SC, Jeong CW, Yoon CY, Hong SK, Byun SS, Lee SE (2012) Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol 53(5):342–348. doi:10.​4111/​kju.​2012.​53.​5.​342 PubMedCrossRefPubMedCentral
9.
go back to reference van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M (2011) Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 30(5):723–728. doi:10.1002/nau.21097 PubMedCrossRef van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M (2011) Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 30(5):723–728. doi:10.​1002/​nau.​21097 PubMedCrossRef
10.
go back to reference Everaerts W, De Ridder D (2013) Unravelling the underactive bladder: a role for TRPV4? BJU Int 111(2):353–354PubMedCrossRef Everaerts W, De Ridder D (2013) Unravelling the underactive bladder: a role for TRPV4? BJU Int 111(2):353–354PubMedCrossRef
12.
go back to reference Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 65(2):389–398. doi:10.1016/j.eururo.2013.10.015 PubMedCrossRef Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 65(2):389–398. doi:10.​1016/​j.​eururo.​2013.​10.​015 PubMedCrossRef
13.
go back to reference Sekido N, Jyoraku A, Okada H, Wakamatsu D, Matsuya H, Nishiyama H (2012) A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model. Neurourol Urodyn 31(7):1190–1196. doi:10.1002/nau.21255 PubMedCrossRef Sekido N, Jyoraku A, Okada H, Wakamatsu D, Matsuya H, Nishiyama H (2012) A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model. Neurourol Urodyn 31(7):1190–1196. doi:10.​1002/​nau.​21255 PubMedCrossRef
15.
17.
go back to reference Tomoe (2014) Assessment of the usefulness and optimal method of administration of distigmine bromide for the treatment of voiding dysfunction due to underactive detrusor. Paper presented at the AUGS/IUGA Scientific Meeting, Washington, DC, July 22–26 Tomoe (2014) Assessment of the usefulness and optimal method of administration of distigmine bromide for the treatment of voiding dysfunction due to underactive detrusor. Paper presented at the AUGS/IUGA Scientific Meeting, Washington, DC, July 22–26
Metadata
Title
Defining and advancing education and conservative therapies of underactive bladder
Authors
Tomas L. Griebling
Catherine E. DuBeau
George Kuchel
Mary H. Wilde
Michelle Lajiness
Hikaru Tomoe
Ananias Diokno
Andrew Vereecke
Michael B. Chancellor
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue Special Issue 1/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0799-6

Other articles of this Special Issue 1/2014

International Urology and Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.